The content below is published for use as a reference or planning tool.
Statement of Need
The need for this activity has been determined based on identifying professional practice gaps, previous course evaluations, and AES self-assessments. The educational content of this activity was based upon current issues and topics provided by the Annual Meeting Committee and membership.
Neurologists, epileptologists, pediatric neurologists, nurses, psychologists, neuropsychologists, nurse practitioners, physician assistants, pharmacists, researchers, and scientists.
Global Learning Objectives
This comprehensive educational meeting provides learners with opportunities to:
- Increase knowledge about the diagnosis and treatment, including novel diagnostic methods and therapeutic modalities of, various manifestations of epilepsy and common comorbidities to enhance clinical practice and improve patient outcomes.
- Be informed about the latest research developments in epilepsy that may translate into clinical care and human therapy in the near future.
- Consider the public health implications of epilepsy and the impact of the disease on patients, communities, and health systems.
NOTE: Each session has its own specific learning objectives, which can be found in the program.
The American Epilepsy Society (AES) promotes research and education for physicians and other healthcare professionals dedicated to the prevention, treatment, and cure of epilepsy. Its continuing professional education (CPE) offers an array of activities to assist the learner in assessing their educational needs and expanding their knowledge, competence and performance in the field of epilepsy, which leads to an improvement in the outcomes of care.
The CPE program always reinforces the fundamental components of epilepsy care in accordance with an Epilepsy Core Curriculum, including quality improvement and patient safety. In addition, its educational interventions also provide an opportunity to advance professional practice in new and emerging areas of the specialty. In recognition of the importance of the added qualification in epilepsy by the American Board of Psychiatry and Neurology as well as the Maintenance of Certification requirements, AES is committed to the provision of educational opportunities and tools that aid in the certification and MOC requirements.
The expected results of AES’s program of continuing professional development are as follows:
- AES’s CPE Program fosters a culture of interprofessional collaboration amongst the cadre of professionals that care for persons with epilepsy.
- AES’s CPE Program enhances the professional practice of healthcare professionals who care for persons with epilepsy.
- The AES’s CPE Program provides education in epilepsy therapy to increase the competence of clinicians in the use of these complex and multi-layered options to manage epilepsy in patients.
- The AES’s CPE Program uses educational interventions as a tool to improve the quality of care and patient safety of persons with epilepsy.
This other activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. The American Epilepsy Society (AES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Category 1 Credit™ Designation
The American Epilepsy Society designates this other activity for a maximum of 58.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The American Medical Association has determined that non-U.S. licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits™.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a minimum of 58.50 hours of Category 1 credit for completing this program.
Continuing Education for Nurses and Pharmacists
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education and the University of Minnesota College of Pharmacy. The National Center for Interprofessional Practice and Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. This activity was planned by and for the healthcare team, and learners will receive Interprofessional Continuing Education (IPCE) credit for learning and change.
The University of Minnesota approves this knowledge-based activity for 41.5 pharmacy contact hours (4.15 CEUs) and 54 nursing contact hours (5.4 CEUs). UAN JA4008105-9999-20-172-L01-P.
Maintenance of Certification
The American Board of Psychiatry and Neurology has reviewed AES2020 and has approved this program as part of the comprehensive Continuing Medical Education (CME) program, which is mandated by the ABMS as a necessary component of maintenance of certification.
Click here for details and instructions about CME and CE credit claiming after the event.
Disclosure Policy and Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity, and scientific rigor. All individuals involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners. In accordance with the ACCME Standards for Commercial Support of CME, AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence.
Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity.
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational, and/or experimental uses.
Basic: Those new to epilepsy treatment or whose background in the specialty is limited, e.g., students, residents, general physicians, general neurologists, neurosurgeons, other professionals in epilepsy care, and administrators.
Intermediate: Epilepsy fellows, epileptologists, epilepsy neurosurgeons, and other providers with experience in epilepsy care (i.e., advanced practice nurses, nurses, and physician assistants), neuropsychologists, psychiatrists, and basic and translational researchers.
Advanced: Address highly technical or complex topics (e.g., neurophysiology, advanced imaging techniques or advanced treatment modalities, including surgery).
Symposia: Topics range from clinically oriented presentations reviewing common issues in epilepsy to more complex topics combining basic sciences and clinical neurology. While target audiences differ, all symposia include discussion of clinically relevant information.
Special Interest Groups (SIG): Offer information and networking for attendees with similar interests, in sessions organized by AES members. Although the sizes of SIG sessions vary, all lend themselves to active participation and dialogue.
Special Lectures: Recognize the accomplishments of distinguished leaders in clinical epilepsy and research. The Judith Hoyer Lecture in Epilepsy is delivered by an AES President Emeritus. The Lennox and Lombroso Lecture is given by an invited member who has greatly advanced the collective understanding of epilepsy.
Annual Course: Encourages in-depth exploration of important topics related to epilepsy, focused on clinical care, including review of the science underlying the topics, reviews of clinical research, and discussion of the associated clinical implications. The Annual Course includes a mixture of educational lectures, clinical vignettes, and panel discussions.
Investigators Workshops: Highlight exciting developments in basic, translational, and clinical epilepsy research in a format promoting interactive discussion. Speakers include established and junior epilepsy investigators, as well as researchers from other fields.
Skills Workshops: Deliver hands-on and interactive learning opportunities in focused clinical areas or basic science research skills. Attendance at each workshop is limited to a small number of participants to allow optimal interaction. Advance registration and an additional fee are required.